CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,166 | 8,332 | ||
| 2019-04-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,771 | 58,687 | ||
| 2019-04-30 | Kennedy Joseph T General Counsel | Option exercise | +2,604 | $1.40 | $4K | 33,864 |
| 2019-04-30 | Kennedy Joseph T General Counsel | Option exercise | +18,750 | $2.50 | $47K | 52,614 |
| 2019-04-30 | Kennedy Joseph T General Counsel | Option exercise | +3,438 | $2.95 | $10K | 56,052 |
| 2019-04-30 | Kennedy Joseph T General Counsel | Option exercise | +2,438 | $3.80 | $9K | 58,490 |
| 2019-04-30 | Kennedy Joseph T General Counsel | Sale | −27,230 | $18.69 | $509K | 31,260 |
| 2019-04-30 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −2,604 | 23,436 | ||
| 2019-04-30 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −18,750 | 37,513 | ||
| 2019-04-30 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −3,438 | 72,186 | ||
| 2019-04-30 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −2,438 | 80,436 | ||
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,605 | $1.40 | $4K | 357,097 |
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +4,166 | $2.50 | $10K | 361,263 |
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,771 | $2.95 | $8K | 364,034 |
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Sale | −9,442 | $20.05 | $189K | 354,592 |
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Sale | −100 | $20.78 | $2K | 354,492 |
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,605 | 26,040 | ||
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,166 | 12,498 | ||
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,771 | 61,458 | ||
| 2019-04-01 | Kennedy Joseph T General Counsel | Option exercise | +2,605 | $1.40 | $4K | 60,807 |
Page 66 of 67 · 1,339 trades